Considering the mechanisms of CDK4/6 inhibition, profound effect that causing tumor regression was rarely observed when CDK4/6 inhibitor was used as a monotherapy in HNSCC [7, 8]. The gene discussed is CDK4; the disease is head and neck squamous cell carcinoma.